Valneva: VLA2001

Vaccine Type: Inactivated

Vaccine Trial & Approval Tracker

This vaccine has reached Phase 3 trials.

About Trial Phases

Phase 1: 1 Trial

  • NCT04671017
    United Kingdom of Great Britain and Northern Ireland

Phase 2: 1 Trial

  • NCT04671017
    United Kingdom of Great Britain and Northern Ireland

Phase 3: 1 Trial

  • NCT04864561
    United Kingdom of Great Britain and Northern Ireland

Approvals

This vaccine is not yet approved.

Registered Trials